About this trial
Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient atrial fibrillation occurring transiently with stress and additional stroke risk factors.
Eligibility criteria
Qualifiers
noncardiac surgery in the past 35 days, with at least an overnight hospital admission aftersurgery;
noncardiac day surgery resulting in a large enough physiological insult to be able to cause AFOTS, as judged by the local investigator; or
acute medical illness requiring hospital admission in the past 35 days and resulting in a large enough physiological insult to be able to cause AFOTS, as judged by the local investigator;
sinus rhythm at the time of randomization;
Disqualifiers
any cardiac diagnosis as the primary reason for hospital admission;
history of documented chronic AF prior to noncardiac surgery;
need for long-term systemic anticoagulation;
ongoing need for long-term dual antiplatelet treatment;
Trial design
Treatments tested in this trial
- Non-vitamin K oral anticoagulant (NOAC)
Treatment groups
Sponsors and collaborators
Population Health Research Institute
Lead sponsor
Hamilton Health Sciences Corporation
Collaborator